A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1248/BPB.35.139PMID 22293342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.

  2011cited by this paper
• Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines.

  2011cited by this paper
• A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats.

  2011cited by this paper
• Innovative preparation of curcumin for improved oral bioavailability.

  2011cited by this paper
• Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials

  2010cited by this paper
• Cyclin-dependent Kinase-9 Is a Component of the p300/GATA4 Complex Required for Phenylephrine-induced Hypertrophy in Cardiomyocytes*

  2010cited by this paper
• Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer

  2010cited by this paper
• Curcumin has bright prospects for the treatment of inflammatory bowel disease.

  2009cited by this paper
• Nanoparticle-based targeted drug delivery.

  2009cited by this paper
• The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.

  2008cited by this paper
• Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

  2008cited by this paper
• Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model

  2007cited by this paper
• Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS.

  2007cited by this paper
• Curcumin for chemoprevention of colon cancer.

  2007cited by this paper
• Bioavailability of curcumin: problems and promises.

  2007cited by this paper
• Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

  2006cited by this paper
• Histone Acetyltransferase Activity of p300 Is Required for the Promotion of Left Ventricular Remodeling After Myocardial Infarction in Adult Mice In Vivo

  2006cited by this paper
• Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure

  2003cited by this paper
• Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability.

  2002cited by this paper
• Phosphorylation of GATA-4 Is Involved in α1-Adrenergic Agonist-responsive Transcription of the Endothelin-1 Gene in Cardiac Myocytes*

  2000cited by this paper
• cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction.

  1997cited by this paper
• Article in Press International Journal of Pharmaceutics Curcumin and Its Nano-formulation: the Kinetics of Tissue Distribution and Blood–brain Barrier Penetration

  year unknowncited by this paper

• Polyphenols as Adjuvant Treatment for Heart Failure with Preserved Ejection Fraction (HFpEF): A Review

  2026cites this paper
• Nanocurcumin in myocardial infarction therapy: emerging trends and future directions

  2025cites this paper
• Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice

  2024cites this paper
• Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms

  2023cites this paper
• Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex

  2022cites this paper
• Potential of natural products in the treatment of myocardial infarction: focus on molecular mechanisms

  2022cites this paper
• Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis

  2022cites this paper
• Systematic review and meta-analysis of the intervention effect of curcumin on rodent models of myocardial infarction

  2022influential citation
• Auraptene, a citrus peel-derived natural product, prevents myocardial infarction-induced heart failure by activating PPARα in rats.

  2022cites this paper
• Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study

  2022cites this paper
• A novel amorphous preparation improved curcumin bioavailability in healthy volunteers: A single-dose, double-blind, two-way crossover study

  2021cites this paper
• Acetyltransferase p300 Is a Putative Epidrug Target for Amelioration of Cellular Aging-Related Cardiovascular Disease

  2021cites this paper
• Anti-Inflammatory Effect of Curcumin on the Mouse Model of Myocardial Infarction through Regulating Macrophage Polarization

  2021cites this paper
• Inhibiting NF-κB During Cytokine Storm in COVID-19: Potential Role of Natural Products as a Promising Therapeutic Approach

  2021cites this paper
• Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases

  2021cites this paper
• [The Therapeutic Potency of Natural Products against Heart Failure].

  2020cites this paper
• Daphnetin suppresses experimental abdominal aortic aneurysms in mice via inhibition of aortic mural inflammation

  2020cites this paper
• The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice

  2020cites this paper
• Nanodelivery of Natural Antioxidants: An Anti-aging Perspective

  2020cites this paper
• Theracurmin (Highly Bioavailable Curcumin) Prevents High Fat Diet-Induced Hepatic Steatosis Development in Mice

  2019cites this paper
• Application of curcumin-loaded nanocarriers for food, drug and cosmetic purposes

  2019cites this paper
• Nanodelivery of phytobioactive compounds for treating aging-associated disorders

  2019cites this paper
• Highly Dispersible and Bioavailable Curcumin but not Native Curcumin Induces Brown‐Like Adipocyte Formation in Mice

  2018cites this paper
• Protective effects and mechanism of curcumin on myocardial injury induced by coronary microembolization

  2018cites this paper
• Curcumin in heart failure: A choice for complementary therapy?

  2018cites this paper
• [Noble Heart Failure Therapy Using Food Compositions].

  2018cites this paper
• Therapeutic Potential and Recent Advances of Curcumin in the Treatment of Aging-Associated Diseases

  2018cites this paper
• The Holy Grail of Curcumin and its Efficacy in Various Diseases: Is Bioavailability Truly a Big Concern?

  2017cites this paper
• Curcumin β-D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the Blood.

  2017cites this paper
• A Novel Target Molecule of Nobiletin Derived from Citrus Peels has a Therapeutic Potency Against the Development of Heart Failure.

  2017cites this paper
• Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells

  2017cites this paper
• Effects of curcumin on the apoptosis of cardiomyocytes and the expression of NF-κB, PPAR-γ and Bcl-2 in rats with myocardial infarction injury

  2016cites this paper
• Clinical applications of curcumin

  2015cites this paper
• Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study.

  2015cites this paper
• Highly bioavailable curcumin (Theracurmin): Its development and clinical application

  2015cites this paper
• Preparation, characterisation and evaluation of curcumin with piperine-loaded cubosome nanoparticles

  2014cites this paper
• Optimal dose-setting study of curcumin for improvement of left ventricular systolic function after myocardial infarction in rats.

  2014cites this paper
• Curcumin Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm by Inhibition of Inflammatory Response and ERK Signaling Pathways

  2014cites this paper
• Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.

  2014cites this paper
• Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes.

  2013cites this paper
• Drinkable preparation of Theracurmin exhibits high absorption efficiency--a single-dose, double-blind, 4-way crossover study.

  2013cites this paper
• Combination of D942 With Curcumin Protects Cardiomyocytes From Ischemic Damage Through Promoting Autophagy

  2013influential citation
• Clinical Application of “Curcumin”, a Multi-Functional Substance

  2012cites this paper